Author:
Fernandes H.,Batalha V.L.,Bonifácio M.J.,Vieira-Coelho M.A.,Soares-da-Silva P.
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference5 articles.
1. Anxiety Disorders and anxiolytics, in: Stahl's essential psychopharmacology, Neuroscientific basis and practical applications;Stahl,2013
2. Mexazolam in Anxiety Disorders: Results of a Multicenter Trial;Coelho;Advances in Therapy,1997
3. Psychomotor Effects of Mexazolam vs;Silveira;Placebo in Healthy Volunteers. Clin. Drug. Invest.,2002
4. Psychomotor and Anxiolytic Effects of Mexazolam in Patients with Generalised Anxiety Disorder;Ferreira;Clin. Drug. Invest.,2003
5. Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg;Leufkens;Psychopharmacology (Berl),2007